ES2064759T3 - Procedimiento de obtencion a partir de la caseina beta, de fracciones enriquecidas en peptidos con actividad biologica, y las fracciones peptidicas obtenidas. - Google Patents

Procedimiento de obtencion a partir de la caseina beta, de fracciones enriquecidas en peptidos con actividad biologica, y las fracciones peptidicas obtenidas.

Info

Publication number
ES2064759T3
ES2064759T3 ES90913211T ES90913211T ES2064759T3 ES 2064759 T3 ES2064759 T3 ES 2064759T3 ES 90913211 T ES90913211 T ES 90913211T ES 90913211 T ES90913211 T ES 90913211T ES 2064759 T3 ES2064759 T3 ES 2064759T3
Authority
ES
Spain
Prior art keywords
carried out
fractions
casein
precursors
hydrolysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913211T
Other languages
English (en)
Inventor
Joelle Leonil
Francoise Nau
Daniel Molle
Jean Louis Maubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Application granted granted Critical
Publication of ES2064759T3 publication Critical patent/ES2064759T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PARA OBTENER, A PARTIR DE CASEINA BETA, UN HIDROLIZATO PARCIAL ENRIQUECIDO, POR UNA PARTE CON UN FOSFOPEPTIDO O UNA FRACCION PEPTIDICA 1-25, Y POR OTRA PARTE, CON PRECURSORES DE LA BETA-CASOMORFINA (SIENDO ESTOS PRECURSORES FRAGMENTOS QUE CUBREN LA ZONA 33-97 DE LA MOLECULA DE CASEINA BETA) POR HIDROLISIS DE LA CASEINA BETA POR UNA ENZIMA PROTEOLITICA, SE LLEVA ESTE HIDROLISIS EN MEDIO SALINO, QUE PROVOCA LA APARICION EN EL MEDIO DE UN PRECIPITADO QUE SE SEPARA DE LA FASE SOLUBLE, LA CUAL CONSTITUYE EL HIDROLISATO PARCIAL BUSCADO. PREFERENTEMENTE, SE CONDUCE ESTA HIDROLISIS EN UN MEDIO DE UNA FUERZA IONICA EQUIVALENTE A LA DE UNA SOLUCION DE SAL MONOVALENTE COMPRENDIDA ENTRE 0,5 Y 4M. PARA OBTENER LA FRACCION PEPTIDICA 1-25 Y LOS PRECURSORES DE LA BETA-CASOMORFINA, SE CONDUCE UNA CROMOTOGRAFIA DE CAMBIO DE IONES SOBRE ESTA FASE SOLUBLE, DESPUES DE HABERLA DESMINERALIZADO POR ELECTRODIALISIS. PARA OBTENER LA FRACCION PEPTIDICA 177-183 DE ACTIVIDAD ANTIHIPERTENSIVA E INMUNOESTIMULANTE, SE RESOLUBILIZA EL PRECIPITADO OBTENIDO, SE LLEVA LA SOLUCION RESULTANTE A UN PH DE 6-9, Y SE LLEVA A CABO UNA HIDROLISIS POR UNA ENZIMA PROTEOLITICA.
ES90913211T 1989-08-16 1990-08-16 Procedimiento de obtencion a partir de la caseina beta, de fracciones enriquecidas en peptidos con actividad biologica, y las fracciones peptidicas obtenidas. Expired - Lifetime ES2064759T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8910931A FR2650955B1 (fr) 1989-08-16 1989-08-16 Procede d'obtention, a partir de la caseine beta, de fractions enrichies en peptides a activite biologique et les fractions peptidiques obtenues

Publications (1)

Publication Number Publication Date
ES2064759T3 true ES2064759T3 (es) 1995-02-01

Family

ID=9384733

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913211T Expired - Lifetime ES2064759T3 (es) 1989-08-16 1990-08-16 Procedimiento de obtencion a partir de la caseina beta, de fracciones enriquecidas en peptidos con actividad biologica, y las fracciones peptidicas obtenidas.

Country Status (7)

Country Link
EP (1) EP0487619B1 (es)
AT (1) ATE112683T1 (es)
DE (1) DE69013350T2 (es)
DK (1) DK0487619T3 (es)
ES (1) ES2064759T3 (es)
FR (1) FR2650955B1 (es)
WO (1) WO1991002539A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242415A (en) * 1991-04-19 1993-10-26 Univ Melbourne Preparation of anticariogenic phosphopeptides from casein
AU677230B2 (en) * 1992-09-22 1997-04-17 New Zealand Dairy Board A process for producing beta-casein enriched products
JP3782837B2 (ja) * 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法
IT1277964B1 (it) * 1995-12-27 1997-11-12 Biosistema Di Pier Luigi Spara Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso
CN1370054A (zh) * 1999-08-24 2002-09-18 明治制果株式会社 用于促进哺乳动物生长的组合物以及利用该组合物促进哺乳动物生长的方法
FR2841473B1 (fr) * 2002-06-27 2004-09-17 Ingredia Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
JPS59159793A (ja) * 1983-02-28 1984-09-10 Meiji Seika Kaisha Ltd カゼインホスホペプチドの精製法
JPS62270533A (ja) * 1986-05-20 1987-11-24 Agency Of Ind Science & Technol 経口摂食物

Also Published As

Publication number Publication date
DE69013350D1 (de) 1994-11-17
EP0487619B1 (fr) 1994-10-12
EP0487619A1 (fr) 1992-06-03
ATE112683T1 (de) 1994-10-15
DK0487619T3 (da) 1995-03-13
FR2650955A1 (fr) 1991-02-22
WO1991002539A1 (fr) 1991-03-07
DE69013350T2 (de) 1995-03-23
FR2650955B1 (fr) 1992-01-10

Similar Documents

Publication Publication Date Title
ES557358A0 (es) Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico.
DE69029657D1 (de) Menschliches cytokin, interleukin-9
CA2099138A1 (en) Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same
US3357894A (en) Proteolytic enzymes of pig pancreas
ATE126970T1 (de) Proteinhydrolysate.
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
CA2025598A1 (en) Chimaeric hepadnavirus core antigen proteins
WO2000034474A3 (en) Growth factor homolog zvegf3
ES2064759T3 (es) Procedimiento de obtencion a partir de la caseina beta, de fracciones enriquecidas en peptidos con actividad biologica, y las fracciones peptidicas obtenidas.
Ezra et al. Purification and partial sequencing of human placental alkaline phosphatase
Bhattacharyya et al. Studies on structural relationship between two glyco-proteins isolated from alveoli of patients with alveolar proteinosis
Furukawa et al. Isolation and characterization of nerve growth factor from the venom of Naja naja atra
SU1487817A3 (ru) Способ выделения карбоксипепти|дазы в из поджелудочной железы млекопитающих животных
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
Moss Separation of Serum 5′-Nucleotidase and Non-specific Alkaline Phosphatase Activities
CA2128647A1 (en) Chondrocyte protein
CA2310677A1 (en) In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
ABDEL-FATTAH et al. Purification and proteolytic action of milk-clotting enzyme produced by Penicillium citrinum
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
Landais et al. Localization of γ-Glutamyl-phosphate residues to the α2CB3–5 Peptide of type I Chicken bone collagen
Yun et al. Identification of Rhizobium fredii and Bradyrhizobium japonicum by Polyacrylamide Gel Electrophoresis
JPS55115856A (en) Active polypeptide and its preparation
DE3688974D1 (de) Expressionssysteme zur überproduktion gewünschter proteine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 487619

Country of ref document: ES